Steven Edelman, MD and Robert Henry, MD explain the clinical characteristics that would lead to the use of a DPP-4 inhibitor versus a GLP-1 receptor agonist. They discuss…
This month in Discussions in Diabetes, Steven Edelman, MD, and Robert Henry, MD, discuss how physicians can use incretins to help patients with type 2 diabetes reach their…
This month in Discussions in Diabetes, Steve Edelmen, MD, and Jeremy Pettus, MD, delve into continuous glucose monitoring, a new innovation for patients with Type 1 and Type…
Steven Edelman, MD and Robert Henry, MD explain the clinical characteristics that would lead to the use of a DPP-4 inhibitor versus a GLP-1 receptor agonist. They discuss…
This month in Discussions in Diabetes, Steven Edelman, MD, and Robert Henry, MD, discuss how physicians can use incretins to help patients with type 2 diabetes reach their…
This month in Discussions in Diabetes, Steve Edelmen, MD, and Jeremy Pettus, MD, delve into continuous glucose monitoring, a new innovation for patients with Type 1 and Type…
This month in Discussion in Diabetes, Steve Edelmen, MD, and Jeremy Pettus, MD, delve into continuous glucose monitoring, a new innovation for patients with Type 1 and Type…
This month in Discussion in Diabetes, Steven Edelman, MD, discusses strategies to help prevent diabetes in your patients. He looks at key risk factors to monitor as well…
